Barry D. Quart
2019
Compensation breakdown
| Non-Equity Incentive Plan | $306,715 |
|---|---|
| Option Awards | $4,916,373 |
| Salary | $638,991 |
| Other | $8,400 |
| Total | $5,870,479 |
Quart received $4.9M in option awards, accounting for 84% of the total pay in 2019.
Quart also received $306.7K in non-equity incentive plan, $639K in salary and $8.4K in other compensation.
Rankings
In 2019, Barry D. Quart's compensation ranked 1,769th out of 13,971 executives tracked by ExecPay. In other words, Quart earned more than 87.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,769 out of 13,971 | 87th |
Division Manufacturing | 628 out of 5,692 | 89th |
Major group Chemicals And Allied Products | 188 out of 2,189 | 91st |
Industry group Drugs | 151 out of 1,875 | 92nd |
Industry Pharmaceutical Preparations | 113 out of 1,387 | 92nd |
Pay ratio
| Barry D. Quart's Pay | $5,870,479 |
|---|---|
| Median Employee's Pay | $408,623 |
| Pay Ratio | 14to 1 |
In 2019, the annual total compensation of Barry D. Quart was $5,870,479.
The annual total compensation of the median employee at Heron Therapeutics was $408,623.
The ratio of Barry D. Quart's pay to the pay of median employee was therefore 14 to one.
Quart's colleagues
We found four more compensation records of executives who worked with Barry D. Quart at Heron Therapeutics in 2019.
News
May 1, 2023
April 25, 2022
April 22, 2021
April 23, 2020